2nd Quarter - Report

STRYKER CORPORATION for STRYKER CORPORATION

Period 2nd Quarter 2011 Filed Jul 19, 2011 Signed by Page Kranbuhl, Director, U.S. Government Affairs

Official filing
Firm
STRYKER CORPORATION
Client
STRYKER CORPORATION
Income
—
Expenses
$80,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly Accountable Care Organizations, the Independent Payment Advisory Board, the Sunshine Act, and the medical device tax. Reform of the FDA 510(k) regulatory pathway Reauthorization of the Medical Device User Fee Program

LobbyistCovered position, as disclosed
PAGE KRANBUHL Senate HELP Subcommittee staff
ERIC RUGO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.